October 1, 2016 / 9:51 AM / in a year

BRIEF-Morphosys reports positive results from psoriasis study

Oct 1 (Reuters) - Morphosys AG

* Morphosys announces that its licensee Janssen reports positive results from a phase 3 study of Guselkumab in plaque psoriasis Source text for Eikon: Further company coverage: (Reporting By Georgina Prodhan)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below